Predicting the future of health

Once infected by SARS-CoV-2, would you like to know your health status evolution?

 

This is Biosfer Teslab commitment in the SARS-CoV-2 pandemic.

The Spanish Institute of Health Research Pere Virgili, Fundación Alcorcón University Hospital, SCIENCE&STRATEGY SL, Laboratorios Rubió SA, and Biosfer Teslab together with Treat systems (Denmark), Kinesys Consulting (UK), EuroCrime (Italy) have built a consortium to fight the SARS-CoV-2 pandemic. In only 10 days we have succeeded in building a strong consortium and drafting the proposal from scratch presented  to the H2020 emergency call, SC1-PHE-CORONAVIRUS-2020-2B. We turned a nearly impossible task into a reality thanks to the guidance of Dr. Marco Straccia (FRESCI by SCIENCE&STRATEGY) helped by a very skilful project manager, Dr. Lydia Cabau.

VISIONING, the project name, aims to help predicting the clinical evolution of COVID-19 patients by using NMR metabolomics combined with artificial intelligence (AI). After our Liposcale test, this metabolomic AI-prognostic tool for COVID-19 represents another big effort of Biosfer Teslab in bringing cost-effective personalized and precision medicine smart health applications into the clinical practice

We are very thankful to  the NMR network who supports our project, particularly Teodor Parella (Universitat Autonoma Barcelona), Maria Luisa-Garcia (BIONAND), Oscar Millet (BIOGUNE), Dr. Albert Sickmann (ISAS), Claudio López (Chile University), Thomas Haack (Andinno, CL), Mirko Mori and Stefano Cacciatore (Prometheus Metabolomics LTD) Dr. Yuste (CEBAS -CSIC) and Dr. Nelson Alexandre da Cruz (Sharjah Institute for Medical Research).

At Biosfer Teslab, we are researchers committed in advancing medicine with precision and smart health solutions.

Contact us if you want to know more about our services.